Previous 10 | Next 10 |
While stocks that go hyperbolic in a bull market may garner more attention during their climb phase, companies that are capable of thriving in turbulent markets may be more valuable to investors over the long term. That second type of resilience is a critical attribute that Nasdaq-liste...
Summary Medpace Holdings continues its period of growth with another set of strong quarterly numbers last period. In addition to the strong beat at the top and bottom lines, profitability trends continued to track higher. Even after the post-earnings jump in price action share...
Summary Medpace Holdings surpasses market estimates for revenue and earnings under tough economic conditions. Along with revenue and earnings, many of the numbers were positive in the last quarter, including new business awarded, full-year guidance, backlog and stock buybacks. ...
Shares of Medpace Holdings (NASDAQ: MEDP) , a clinical contract research organization (CRO) that supplies clinical development services to the biotechnology, pharmaceutical, and medical device industries, rose 41.5% this week, according to data from S&P Global Intelligence ....
Shares of Medpace Holdings (NASDAQ: MEDP) surged 37.7% on Tuesday after the clinical contract research organization (CRO) delivered strong third-quarter results and issued an optimistic financial forecast for the year ahead. Medpace's revenue jumped 30% year over year to ...
Medpace Holdings, Inc. (MEDP) Q3 2022 Results Conference Call October 25, 2022 09:00 AM ET Company Participants Lauren Morris - IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants Dave Windley - Jefferi...
Beats on the top and bottom line in its Q3 2022 financial results have propelled Medpace Holdings ( NASDAQ: MEDP ) shares 20% higher in after-hours trading. Net income in the quarter rose ~36% compared to the prior-year period to $66M ($2.05 EPS diluted vs. $1.29 E...
Medpace press release ( NASDAQ: MEDP ): Q3 GAAP EPS of $2.05 beats by $0.57 . Revenue of $383.7M (+29.8% Y/Y) beats by $26.53M . Net new business awards were $470.9 million in the third quarter of 2022, representing an increase of 15.4% from net new business aw...
Revenue of $383.7 million in the third quarter of 2022 increased 29.8% from revenue of $295.6 million for the comparable prior-year period, representing a backlog conversion rate of 17.7%. Net new business awards were $470.9 million in the third quarter of 2022, represen...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2022 financial results after the market close on Monday, October 24, 2022. The Company will host a conference call the following morning, Tuesday, October 25, 2022, at 9...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...